Sfoglia per Autore HARARI, SERGIO ALFONSO
Cisplatin and radiotherapy in the treatment of unresectable lung cancer
1987 E. Soresi, U. Borghini, S. Harari, S. Scoccia, M. Torre, M. Botturi, M. Leoni
Salmon calcitonin in cancer pain: comparison between two different treatment schedules
1987 G.F. Schiraldi, E. Soresi, S. Locicero, S. Harari, S. Scoccia
Utilità della somministrazione di retinolo palmitato ai pazienti operati di carcinoma polmonare non microcitoma in 1st stadio 'A'
1989 E. Soresi, U. Pastorino, G. Chiesa, M. Clerici, G. Invernizzi, S. Harari, B. Brando
Early infections and bronchiolitis obliterans-organizing pneumonia in single lung transplant recipients
1992 M. Barberis, D. Bauer, S. Harari, P.A. Belloni, T. Masini, A. Baisi
Role of CMV pneumonia in the development of obliterative bronchiolitis in heart-lung and double-lung transplant recipients
1992 J. Cerrina, F. Le Roy Ladurie, P.H. Herve, F. Parquin, S. Harari, A. Chapelier, G. Simoneau, P. Vouhe, P.H. Dartevelle
Proliferating cell nuclear antigen immunostaining of the endothelial cells in lung transplantation
1992 M. Barberis, S. Harari
Recurrence of primary disease in a single lung transplant recipient
1992 M. Barberis, S. Harari, A. Tironi, P. Lampertico
Ipertensione polmonare in corso di malattie interstiziali, incidenza e rilevanza clinico-prognostica
1993 S. Harari, G. Simonneau, F. Brenot, P. Colombo, E. Micallef, F. Parent, F. Ziglio, S. Scoccia
Unusually high plasma CEA values in a patient with idiopathic pulmonary fibrosis
1994 S. Harari, M. Costantini, P. Ghio, S. Scoccia
Selection and evaluation of recipients for heart-lung and lung transplantation: The Niguarda Hospital experience
1994 S. Harari, G. Ziglio, F. Ioli, E. De Juli, C.F. Donner, E. Gronda, E. Micallef, M. Ravini, S. Scoccia
Rejection and nonrejection related forms of bronchiolitis obliterans: Morphologic terms or clinico-pathological entities?
1995 M. Barberis, S. Harari, M. Bramerio, E. Minola, E. Bonacina, M. Gambacorta
Immunocytochemical detection of progesterone receptors. A study in a patient with primary pulmonary hypertension
1995 M.C. Barberis, S. Veronese, D. Bauer, E. De Juli, S. Harari
Primary pulmonary hypertension: Do we consider the right risk factors?
1996 S. Harari, M. Ciccarelli, E. De Juli, P. Paredi, G. Ziglio, E. Micallef
Terbinafine in the treatment of non-immunocompromised compassionate cases of bronchopulmonary aspergillosis
1996 G.F. Schiraldi, M.D. Colombo, S. Harari, S. Lo Cicero, G. Ziglio, M. Ferrarese, D. Rossato, E. Soresi
The diagnosis of lymphangioleiomyomatosis (LAM) and histiocytosis X (Hx) need to be histologically proven?
1996 S. Harari, M. Barberis, E. De Juli, F. Colombo, G. Cimino, L. Sabolla, E. Soresi
Advanced pulmonary histiocytosis X is associated with severe pulmonary hypertension [3]
1997 S. Harari, F. Brenot, M. Barberis
Terbinafina: Un nuovo farmaco antimicotico nel trattamento dell'aspergillosi polmonare : Studio pilota
1997 G. Schiraldi, S. Lo Cicero, D. Rossato, M. Ferrarese, G. Ziglio, S. Harari, C. Dinoia, R. Boffi, E. Soresi
Relapsing Aspergillus bronchitis in a double lung transplant patient, successfully treated with a new oral antimycotic agent
1997 S. Harari, G. Schiraldi, E. De Juli, E. Gronda
Absence of hyperhomocysteinemia in ten patients with primary pulmonary hypertension
1997 M. Zighetti, M. Cattaneo, C. Falcon, R. Lombardi, S. Harari, S. Savoritto, P. Mannucci
Prognostic value of pulmonary hypertension in patients with chronic interstitial lung disease referred for lung or heart-lung transplantation
1998 S. Harari, G. Simonneau, E. De Juli, F. Bressot, J. Cerrina, P. Colombo, E. Gronda, E. Micallef, F. Parent, P. Dartevelle
Legenda icone
- file ad accesso aperto
- file disponibili sulla rete interna
- file disponibili agli utenti autorizzati
- file disponibili solo agli amministratori
- file sotto embargo
- nessun file disponibile